XML 22 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Equity Method Investments
12 Months Ended
Dec. 31, 2019
Equity Method Investments  
Equity Method Investments

Note 13. Equity Method Investments

Associates consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

December 31, 2019

 

 

 

 

Place of

 

 

 

 

 

 

 

 

 

Name of

 

Principal

 

Incorporation

 

Carrying

 

Holding

 

Carrying

 

Holding

Associate

    

Activities

    

and operation

    

amount

    

%

    

amount

    

%

 

 

 

 

 

 

(in thousands)

 

 

 

(in thousands)

 

 

Ganzin Technology Corp.

 

Eye tracking chip and module

 

Taipei, Taiwan

 

$

1,473

 

49.32

 

1,156

 

49.35

Iris Optronics Co., Ltd.

 

E-paper manufacturing and sales

 

Tainan, Taiwan

 

 

44

 

1.55

 

41

 

1.25

Kneron Inc.

 

Artificial intelligence chip design

 

California, USA

 

 

-

 

-

 

-

 

-

Viewsil Microelectronics (Kunshan) Limited

 

IC design and sales

 

Kunshan, China

 

 

2,547

 

49.00

 

2,549

 

49.00

 

 

  

 

  

 

$

4,064

 

  

 

3,746

 

  

 

In April 2018, the Company assessed its relationships with Kneron Inc. and determined that it is no longer able to exercise significant influence over Kneron Inc. Therefore, the Company reclassified its investment in Kneron Inc. as financial assets at fair value through profit or loss. The difference between the fair value of the investment and carrying amount accounted for under the equity method as at the date of the reclassification was recognized in profit or loss. In total, a gain of $2,094 thousand was recognized under changes in fair value of financial assets at fair value through profit or loss in the consolidated statement of profit or loss for the year ended December 31, 2018.

There is no individually significant associate for the Company. The following table summarized the amount recognized by the Company at its share of those associates:

 

 

 

 

 

 

 

 

 

 

For the year ended

 

 

December 31, 

 

    

2017

 

2018

    

2019

 

 

(in thousands)

 

 

 

 

 

 

 

 

The Company’s share of losses of associates

 

$

(1,200)

 

(1,095)

 

(477)

The Company’s share of other comprehensive income (loss) of associates

 

$

106

 

(68)

 

26

The Company’s share of total comprehensive income (loss) of associates

 

$

(1,094)

 

(1,163)

 

(451)

 

As of December 31, 2018 and 2019, none of the Company’s equity method investments was pledged as collateral.